Arcoma AB (STO:ARCOMA)
Sweden · Delayed Price · Currency is SEK 7.48
+0.18 (2.47%)
Feb 10, 2026, 4:31 PM CET
Arcoma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 132.94 | 156.81 | 163.02 | 125.05 | 117.13 | 117.42 | |
Revenue Growth (YoY) | -22.41% | -3.81% | 30.36% | 6.76% | -0.24% | -12.16% |
Cost of Revenue | 79.17 | 94.2 | 105.1 | 74.6 | 75.48 | 72.17 |
Gross Profit | 53.77 | 62.61 | 57.91 | 50.45 | 41.65 | 45.25 |
Selling, General & Admin | 39.06 | 42.79 | 45.25 | 42.87 | 44.6 | 38.31 |
Other Operating Expenses | -0.53 | -1.77 | -0.09 | -2.15 | -0.29 | 0.13 |
Operating Expenses | 46.1 | 48.96 | 53.25 | 47.32 | 50.44 | 41.74 |
Operating Income | 7.67 | 13.65 | 4.66 | 3.13 | -8.79 | 3.51 |
Interest Expense | -0.12 | -0.26 | -1.39 | -0.9 | -0.76 | -0.54 |
Interest & Investment Income | 0.14 | 0.12 | - | - | 0 | 0.02 |
Earnings From Equity Investments | -0 | -0 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.2 | 0.25 | -0.14 | -0.1 | 0.64 | -1.24 |
Other Non Operating Income (Expenses) | - | - | 0 | -0 | - | - |
EBT Excluding Unusual Items | 7.88 | 13.77 | 3.13 | 2.12 | -8.91 | 1.75 |
Pretax Income | 7.88 | 13.77 | 3.13 | 2.12 | -8.91 | 1.75 |
Income Tax Expense | 1.57 | 2.59 | 0.57 | 0.22 | -1.44 | 0.38 |
Net Income | 6.32 | 11.18 | 2.56 | 1.9 | -7.47 | 1.37 |
Net Income to Common | 6.32 | 11.18 | 2.56 | 1.9 | -7.47 | 1.37 |
Net Income Growth | -42.64% | 336.00% | 34.80% | - | - | -79.35% |
Shares Outstanding (Basic) | 14 | 13 | 13 | 13 | 13 | 13 |
Shares Outstanding (Diluted) | 14 | 13 | 13 | 13 | 13 | 13 |
Shares Change (YoY) | 6.39% | - | 0.93% | 0.94% | 1.68% | 0.66% |
EPS (Basic) | 0.45 | 0.85 | 0.19 | 0.15 | -0.58 | 0.11 |
EPS (Diluted) | 0.45 | 0.85 | 0.19 | 0.15 | -0.58 | 0.11 |
EPS Growth | -45.81% | 336.00% | 33.56% | - | - | -79.48% |
Free Cash Flow | 9.57 | 18.84 | 19.16 | -0.19 | -2.62 | 6.1 |
Free Cash Flow Per Share | 0.68 | 1.43 | 1.45 | -0.01 | -0.20 | 0.48 |
Gross Margin | 40.45% | 39.93% | 35.53% | 40.34% | 35.55% | 38.54% |
Operating Margin | 5.77% | 8.71% | 2.86% | 2.50% | -7.51% | 2.99% |
Profit Margin | 4.75% | 7.13% | 1.57% | 1.52% | -6.38% | 1.16% |
Free Cash Flow Margin | 7.20% | 12.02% | 11.75% | -0.15% | -2.24% | 5.20% |
EBITDA | 8.22 | 14.57 | 6.25 | 4.78 | -7.3 | 4.97 |
EBITDA Margin | 6.18% | 9.29% | 3.83% | 3.82% | -6.23% | 4.24% |
D&A For EBITDA | 0.55 | 0.92 | 1.59 | 1.66 | 1.5 | 1.47 |
EBIT | 7.67 | 13.65 | 4.66 | 3.13 | -8.79 | 3.51 |
EBIT Margin | 5.77% | 8.71% | 2.86% | 2.50% | -7.51% | 2.99% |
Effective Tax Rate | 19.88% | 18.80% | 18.19% | 10.32% | - | 21.91% |
Revenue as Reported | 135.72 | 160.45 | 165.99 | 129.88 | 117.97 | 117.91 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.